F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure medications were administered to meet the needs
of each resident and in accordance with professional standards of practice for one of two sampled
residents (Resident 1) and 3 of 4 medications (anticonvulsant, antipsychotic, and insulin). Resident 1 had
three consecutive episodes of noncompliance behavior (refused medications, on 8/2, 8/3, 8/4/2025
[anticonvulsant], on 8/9, 8/10, 8/11/2025 [antipsychotic], and on 8/2, 8/3, 8/4/2025 [insulin]) for three
different medications and the doctor was not notified, per the care plan interventions. In addition, Resident
1's blood glucose was not obtained prior to administration of insulin, in accordance with the policy and
procedure titled, Medication - Administration, revised 11/1/2017. These deficient practices caused an
increased risk in unsafe and inappropriate care of Resident 1, medication errors, and adverse outcomes to
the resident. Findings: During a review of Resident 1's admission Record, the admission Record indicated
Resident 1 was admitted to the facility on [DATE] with diagnoses including depression (severe feelings on
sadness and hopelessness), schizoaffective disorder bipolar type (a mental illness that causes loss of
contact with reality which features episodes of mania which can include feelings of euphoria, racing
thoughts, and increased risky behavior as well as major depressive episodes), psychosis (a mental
disorder characterized by a disconnection from reality), anxiety disorder, insomnia, and type 2 diabetes
mellitus (a disease that occurs when there is a problem in the way the body regulates and uses sugar as
fuel). During a review of Resident 1's Minimum Data Set (MDS, a resident assessment tool), dated
7/16/2025, the MDS indicated the resident had moderately impaired cognitive skills for daily decision
making (problems with thinking, memory and judgement). The MDS indicated Resident 1 had verbal
behavioral symptoms directed towards others which occurred one to three days and other behavioral
symptoms not directed toward others which occurred daily. The MDS also indicated Resident 1 was taking
high-risk drugs such as antipsychotic (drugs that work by altering brain chemistry to help reduce psychotic
symptoms like hallucinations [an experience which a person sees, hears, feels, or smells something that
does not exist], delusions [believed to be true or real but is actually false or unreal], and disordered
thinking), antianxiety (drugs used to prevent or treat anxiety symptoms or disorders), antidepressant (drugs
used to relieve symptoms of depressive disorders), hypoglycemic (low blood sugar) including insulin and
anticonvulsant (drug used to prevent or reduce the severity of seizures or other convulsions). During a
review of the Physician's Order Summary Report, the report indicated Resident 1 was ordered to receive:
-On 7/10/2025, Insulin Glargine Solostar (a long-acting insulin [a hormone that plays a crucial role in
regulating blood glucose levels] used to control hyperglycemia [high blood sugar]) Subcutaneous (applied
under the skin) Solution Pen-Injector 100 unit/milliliter (ml, unit of volume), inject 17 unit subcutaneously
two times a day for type 2 diabetes mellitus hold if blood sugar is less than 150. -On 7/10/2025, Trazodone
HCl Oral Tablet (medication primarily used to treat major
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
055617
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055617
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Pasadena Grove Health Center
1470 N Fair Oaks Ave
Pasadena, CA 91103
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
depressive disorder [a mental health disorder characterized by persistently low mood or loss of interest in
activities, causing significant impairment in daily life], anxiety disorders [persistent and excessive worry that
interferes with daily activities), and insomnia [sleep disorder characterized by difficulty failing asleep,
staying asleep, or both]), give one tablet by mouth at bedtime for depression manifested by inability to sleep
at night. -On 7/18/2025, Divalproex Sodium (an anticonvulsant medication used to treat certain types of
seizures and the manic phase of bipolar disorder) Oral Tablet Delayed Release 500 milligrams (mg, unit of
measurement), give one tablet by mouth every 12 hours for mood disorder manifested by mood swings as
evidenced by irritable mood. -On 7/18/2025, Olanzapine Oral Tablet 10 mg (medication used in the
treatment of schizophrenia), give one tablet by mouth two times a day for schizophrenia manifested by
paranoid delusion (fixed, false beliefs that a resident insists ae true) as evidenced by saying people were
poisoning Resident 1. During a review of Resident 1's care plan, dated 7/10/2025, the care plan indicated
Resident 1 was at risk for clinical or social decline due to history of noncompliance or refusal of medication.
The care plan interventions indicated to monitor episodes of noncompliance and notify doctor for three
episodes of noncompliance behavior consecutively, encourage family of the risks and consequences of
being noncompliant with the plan of care, and discuss with the IDT the resident's behavior of being
noncompliant for any further recommendations. During a review of Resident 1's care plan, dated 8/8/2025,
the care plan indicated Resident 1 was noncompliant with medications and diet. The care plan interventions
indicated to administer medications as ordered, monitor/document for side effects and effectiveness,
explain the importance of the prescribed medication and diet to the resident and the need for adequate
nutritional intake, and obtain and monitor lab/diagnostic work as ordered and report results to doctor and
follow up as indicated. During a review of Resident 1's Medication Administration Record for the month of
August 2025, the MAR indicated as follows:- Divalproex Sodium refused doses: 8/2/2025 PM, 8/3/2025 PM,
8/4/2025 PM, 8/6/2025 PM, 8/9/2025 PM, 8/10/2025 PM, 8/11/2025 PM, and 8/13/2025 PM (eight refused
doses). - Olanzapine refused doses: 8/2/2025 PM, 8/8/2025 AM, 8/9/2025 PM, 8/11/2025 PM (four refused
doses).- Trazodone HCl refused doses: 8/2/2025 PM, 8/9/2025 PM, 8/10/2025 PM, and 8/11/2025 PM (four
refused doses). - Insulin Glargine refused doses: 8/2/2025 AM and PM, 8/3/2025 AM and PM, 8/4/2025
PM, 8/5/2025 PM, 8/6/2025 PM, 8/8/2025 AM, 8/9/2025 AM, 8/10/2025 PM, 8/11/2025 PM, 8/12/2025 PM,
8/13/2025 PM, and 8/14/2025 AM (14 refused doses). - Insulin Glargine was administered, and blood
glucose was not tested by licensed nurse prior to administration for the following doses: 8/1/2025 AM and
PM, 8/4/2025 AM, 8/5/2025 AM, 8/6/2025 AM, 8/7/2025 AM and PM, 8/8/2025 PM, and 8/9/2025 PM (nine
doses of insulin administered without obtaining blood glucose). During a concurrent interview and record
review on 9/3/2025 at 8:10 AM with the Director of Nursing (DON), Resident 1's care plans, nursing notes,
MAR, and SBAR (an acronym for Situation-Background-Assessment-Recommendation is a technique used
to provide a framework for communication between members of the health care team) were reviewed. The
DON stated the doctor should have been notified and was not notified of Resident 1's noncompliance and
refusals with the medications. The DON stated the doctor needed to be informed to possibly adjust the
medications or transfer Resident 1 to another hospital. The DON stated Resident 1 refused the medications
used for mood disorder, schizophrenia, and depression. The DON stated noncompliance with medications
could lead to a decline in Resident 1's behavior and inability to sleep. During a follow up interview and
record review on 9/3/2025 at 9:25 AM with the DON, Resident 1's care plans, nursing notes, MAR, IDT and
SBAR were reviewed. The DON stated licensed nurses did not document the education given to Resident 1
on the MAR progress notes for Resident 1's medication refusals. The DON stated licensed nurses did not
check Resident 1's blood glucose prior to
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055617
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055617
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Pasadena Grove Health Center
1470 N Fair Oaks Ave
Pasadena, CA 91103
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
administering Insulin Glargine and the doctor was not notified of Resident 1's refusal of insulin doses. The
DON stated hyperglycemia could result in Resident 1 going into a coma since her body was unable to
produce enough insulin. The DON also stated the IDT should have addressed and did not address
Resident 1's refusal for blood glucose checks and medication refusals. During a review of the facility's
Policy and Procedure (P&P) titled, Refusal of Treatment, revised 5/1/2023, the policy indicated the Charge
Nurse or DON would document information relating to the refusal in the resident's medication record.
Documentation would include at least the following: a. The date and time a medication or treatment was
attempted. b. The medication or treatment refused.c. The resident's reason(s) for refusal.d. The name of the
person attempting to administer the treatment.e. That the resident was informed (to the extent of their ability
to understand) of the purpose of the treatment and the consequences of not receiving the medication. f.
The residents' condition and any adverse effects due to such refusal.g. The date and time the Attending
Physician was notified and his or her response. The P&P indicated the IDT would assess the resident's
needs and offer the resident alternative treatments while continuing to provide other services in the care
plan. During a review of the facility's P&P titled, Medication - Administration, revised 11/1/2017, the policy
indicated when administration of the drug was dependent upon vital signs or testing, the vital signs/testing
would be completed prior to administration of the medication and recorded in the medical record (i.e., blood
pressure, pulse, finger stick blood glucose monitoring etc.).
Event ID:
Facility ID:
055617
If continuation sheet
Page 3 of 3